Literature DB >> 28509135

Renal-limited vasculitis with elevated levels of multiple antibodies.

Noriaki Sato1, Hideki Yokoi2, Hirotaka Imamaki1,3, Eiichiro Uchino1, Kaoru Sakai1, Takeshi Matsubara1, Tatsuo Tsukamoto1,4, Sachiko Minamiguchi5, Motoko Yanagita1.   

Abstract

Renal-limited vasculitis (RLV) is a type of anti-neutrophil cytoplasmic antibody (ANCA)-associated vasculitis that presents with crescentic glomerulonephritis with no other organ involvement. Although several studies reported patients with crescentic glomerulonephritis who were dual positive for proteinase 3 (PR3)-ANCA and myeloperoxidase (MPO)-ANCA or ANCA and anti-glomerular basement membrane (GBM) antibody, patients positive for all three antibodies, i.e., triple-positive patients, were rarely reported. We herein report the case of a male with pauci-immune type crescentic glomerulonephritis positive for MPO-ANCA, PR3-ANCA, and anti-GBM antibody. Renal biopsy led to the definitive diagnosis of RLV with pauci-immune-type crescentic glomerulonephritis. Fluorescence immunostaining showed no linear deposition of IgG on GBM, indicating no involvement of anti-GBM associated diseases. Intensive therapy, including prednisolone, plasma exchange, and intravenous cyclophosphamide, was effective. We report the case of triple-positive patient with crescentic glomerulonephritis, who was successfully treated with glucocorticoid, plasma exchange, and cyclophosphamide, suggesting that treatment for RLV in the patient with serological triple antibodies positivity in the absence of linear IgG deposition could benefit from the combination therapy regimen for plasma exchange and primary induction of remission against microscopic polyangiitis.

Entities:  

Keywords:  Anti-GBM antibody; Case report; MPO-ANCA; PR3-ANCA

Year:  2017        PMID: 28509135      PMCID: PMC5438812          DOI: 10.1007/s13730-017-0248-3

Source DB:  PubMed          Journal:  CEN Case Rep        ISSN: 2192-4449


  25 in total

1.  Renal histology in ANCA-associated vasculitis: differences between diagnostic and serologic subgroups.

Authors:  Herbert A Hauer; Ingeborg M Bajema; Hans C van Houwelingen; Franco Ferrario; Laure-Hélène Noël; Rüdiger Waldherr; David R W Jayne; Niels Rasmussen; Jan A Bruijn; E Christiaan Hagen
Journal:  Kidney Int       Date:  2002-01       Impact factor: 10.612

Review 2.  Alport's syndrome, Goodpasture's syndrome, and type IV collagen.

Authors:  Billy G Hudson; Karl Tryggvason; Munirathinam Sundaramoorthy; Eric G Neilson
Journal:  N Engl J Med       Date:  2003-06-19       Impact factor: 91.245

Review 3.  Anti-neutrophil cytoplasmic antibody-associated vasculitis, large vessel vasculitis and Kawasaki disease in Japan.

Authors:  Shigeto Kobayashi; Shouichi Fujimoto; Kei Takahashi; Kazuo Suzuki
Journal:  Kidney Blood Press Res       Date:  2010-11-10       Impact factor: 2.687

Review 4.  Coexistence of anti-glomerular basement membrane antibodies and myeloperoxidase-ANCAs in crescentic glomerulonephritis.

Authors:  Abraham Rutgers; Marjan Slot; Pieter van Paassen; Peter van Breda Vriesman; Peter Heeringa; Jan Willem Cohen Tervaert
Journal:  Am J Kidney Dis       Date:  2005-08       Impact factor: 8.860

5.  ANCA as a predictor of relapse: useful in patients with renal involvement but not in patients with nonrenal disease.

Authors:  Michael J Kemna; Jan Damoiseaux; Jos Austen; Bjorn Winkens; Jim Peters; Pieter van Paassen; Jan Willem Cohen Tervaert
Journal:  J Am Soc Nephrol       Date:  2014-10-16       Impact factor: 10.121

6.  Prognostic implication of anti-neutrophil cytoplasmic autoantibodies with myeloperoxidase specificity in anti-glomerular basement membrane disease.

Authors:  X Bosch; E Mirapeix; J Font; X Borrellas; R Rodríguez; A López-Soto; M Ingelmo; L Revert
Journal:  Clin Nephrol       Date:  1991-09       Impact factor: 0.975

7.  ANCA-associated vasculitis with renal involvement: an outcome analysis.

Authors:  Sven Weidner; Steffen Geuss; Syrus Hafezi-Rachti; Andrea Wonka; Harald D Rupprecht
Journal:  Nephrol Dial Transplant       Date:  2004-04-06       Impact factor: 5.992

8.  Sequential development of perinuclear ANCA-associated vasculitis and anti-glomerular basement membrane glomerulonephritis.

Authors:  Jacques Serratrice; Laurent Chiche; Bertrand Dussol; Brigitte Granel; Laurent Daniel; Sophie Jego-Desplat; Patrick Disdier; Laure Swiader; Yvon Berland; Pierre-Jean Weiller
Journal:  Am J Kidney Dis       Date:  2004-03       Impact factor: 8.860

9.  PR3-ANCA: a promising biomarker in primary sclerosing cholangitis (PSC).

Authors:  Laura M Stinton; Chelsea Bentow; Michael Mahler; Gary L Norman; Bertus Eksteen; Andrew L Mason; Gilaad G Kaplan; Bjorn Lindkvist; Gideon M Hirschfield; Piotr Milkiewicz; Angela Cheung; Harry L A Janssen; Marvin J Fritzler
Journal:  PLoS One       Date:  2014-11-14       Impact factor: 3.240

Review 10.  Evidence-based clinical practice guidelines for rapidly progressive glomerulonephritis 2014.

Authors:  Yoshihiro Arimura; Eri Muso; Shoichi Fujimoto; Midori Hasegawa; Shinya Kaname; Joichi Usui; Toshiko Ihara; Masaki Kobayashi; Mitsuyo Itabashi; Kiyoki Kitagawa; Junichi Hirahashi; Kenjiro Kimura; Seiichi Matsuo
Journal:  Clin Exp Nephrol       Date:  2016-06       Impact factor: 2.801

View more
  1 in total

1.  From Kidney to Brain: An Uncommon Severe Relapse of Myeloperoxidase Anti-Neutrophil Cytoplasmic Antibody (MPO-ANCA) Vasculitis.

Authors:  Tiago Araújo; Rúben Maia; João Massano; Luis Mendonça; Joana Guimarães
Journal:  Cureus       Date:  2021-03-31
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.